Plato Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$6.12M |
| 2 |
Eli Lilly
LLY
|
+$2.71M |
| 3 |
Seagate
STX
|
+$2.44M |
| 4 |
GE Vernova
GEV
|
+$2.16M |
| 5 |
Ford
F
|
+$2.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kinross Gold
KGC
|
+$3.49M |
| 2 |
Logitech
LOGI
|
+$1.93M |
| 3 |
Wheaton Precious Metals
WPM
|
+$1.89M |
| 4 |
Pfizer
PFE
|
+$1.82M |
| 5 |
Thomson Reuters
TRI
|
+$1.61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.04% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 11.21% |
| 4 | Communication Services | 10.38% |
| 5 | Consumer Discretionary | 9.53% |
Similar funds
Plato Investment Management's Q1 2026 Portfolio in Review
As of Q1 2026, Plato Investment Management held 554 positions worth $1.49B, down 2.7% from $1.53B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Plato Investment Management deployed $48.3M of net new capital in Q1 2026, opening 41 new positions and adding to 178 existing holdings. Its largest new stake was AstraZeneca: 31,725 shares worth $6.15M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Kinross Gold, an estimated $3.49M trimmed.
- Plato Investment Management's largest Q1 2026 buy was AstraZeneca: 31,725 shares worth $6.15M.
- Plato Investment Management added most to Eli Lilly in Q1 2026, an estimated $2.71M increase.
- Plato Investment Management's biggest Q1 2026 reduction was Kinross Gold, cutting an estimated $3.49M.
- Plato Investment Management fully exited Old Republic International in Q1 2026, selling an estimated $1.14M.
- Plato Investment Management's ten largest holdings make up 33% of its $1.49B portfolio in Q1 2026.
- Plato Investment Management opened 41 new positions and closed 38 in Q1 2026.
- Plato Investment Management's portfolio value fell 2.7% quarter-over-quarter to $1.49B.
Based on Plato Investment Management's 13F filing for Q1 2026, filed 5 May 2026.